Fully human antibodies specific to CADM1

Details for Australian Patent Application No. 2010221186 (hide)

Owner Medarex, Inc. Oxford BioTherapeutics Ltd

Inventors Terrett, Jonathan Alexander; Leblanc, Heidi; Huang, Haichun; Meaddough, Erika; Pan, Chin; Chen, Bingliang; RaoNaik, Chetana

Agent Spruson & Ferguson

Pub. Number AU-A-2010221186

PCT Pub. Number WO2010/102175

Priority 61/209,390 05.03.09 US; 61/209,471 05.03.09 US

Filing date 5 March 2010

Wipo publication date 10 September 2010

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

8 September 2011 PCT application entered the National Phase

  PCT publication WO2010/102175 Priority application(s): WO2010/102175

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010221188-Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer

2010221184-Gate valve with lubricated secondary seal